Industry to publish all Phase III trials in peer-reviewed journals
This article was originally published in SRA
Executive Summary
The International Federation of Pharmaceutical Manufacturers and Associations and its members have committed to submitting the results of all industry-sponsored Phase III clinical trials for publication in scientific peer-reviewed journals. However, Germany’s health technology appraisal institute, IQWiG, said that the IFPMA’s bid to improve transparency does not go far enough to prevent publication bias.